Jay Avasarala, M.D., Ph.D., represented the American Academy of Neurology as its chair (2020-22) and participated in the 18-month long program, organized by MSIF (MS International Federation) along with researchers from across the globe to put together a list of drugs for MS that was later submitted to the WHO for approval. The drugs were selected for safety, efficacy, availability in the local communities and expense.
↧
